Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Rights, Outstanding at beginning of period	446
Number of Rights, Exercised	(175)
Number of Rights, Granted	108	187	94
Number of Rights, Forfeited	(5)
Number of Rights, Outstanding at end of period	374	446
Number of Rights, Exercisable and vested at end of period	111
Number of Rights, Vested and expected to vest at end of period	365
Weighted Average Exercise Price, Outstanding at beginning of period	$ 60.55
Weighted Average Exercise Price, Exercised	$ 55.48
Weighted Average Exercise Price, Granted	$ 72.67
Weighted Average Exercise Price, Forfeited	$ 63.50
Weighted Average Exercise Price, Outstanding at end of period	$ 66.42	$ 60.55
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 60.89
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 66.41
Weighted Average Remaining Contractual Life, Outstanding at end of period	3 years 6 months 4 days
Weighted Average Remaining Contractual Life, Exercisable and vested at end of period	2 years 5 months 16 days
Weighted Average Remaining Contractual Life, Vested and expected to vest at end of period	3 years 6 months
Aggregate Intrinsic Value, Outstanding at end of period	$ 4,323
Aggregate Intrinsic Value, Exercisable and vested at end of period	1,904
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 4,220